Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.

Saved in:
Bibliographic Details
Title: Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.
Authors: Gingele, Stefan1 (AUTHOR) gingele.stefan@mh-hannover.de, Saparilla Pietschmann, Anna Christina1 (AUTHOR), Jendretzky, Konstantin F.1 (AUTHOR), Koch, Moritz1 (AUTHOR), Körner, Gudrun M.1,2 (AUTHOR), Siemer, Janna M.1 (AUTHOR), Konen, Franz Felix1 (AUTHOR), Hümmert, Martin W.1 (AUTHOR), Salge, Friederike1 (AUTHOR), von Hörsten, Jarle1 (AUTHOR), Seeliger, Tabea1 (AUTHOR), Körner, Sonja1 (AUTHOR), Skripuletz, Thomas1 (AUTHOR)
Source: Neurology & Therapy. Feb2026, Vol. 15 Issue 1, p165-177. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-025-00848-1